Understanding peptide-mucin interactions: towards improved topical delivery of antimicrobial peptied (AMPs) to the cystin fibrosis lung

Project Details

StatusFinished
Effective start/end date1/01/1331/12/15

Funding

  • Novartis UK Ltd: £36,000.00